BOS Events

Tillotts Services to Exhibit at BOS 2012 - stand 25

Tillotts Services, specialists in liquid-fill encapsulation will be exhibiting at BOS 2012, stand 26, Marble Hall

Gareth Lewis, Pfizer to present at BOS 2012

Bio2Business is pleased to welcome back to BOS 2012, Gareth Lewis, EU Clinical Operations, Pfizer UK. 

James Willson, Senior Clinical Scientist, Shire Pharmaceuticals to present at BOS 2012

Bio2Business is pleased to welcome Dr James Willson, Senior Clinical Scientist, Shire Pharmaceuticals as a speaker at BOS 2012, 25th Setember, RCP, London. Dr Willson will be presenting on the challenges of monitoring international trial sites and how sponsor and vendor can work in partnership to approach these challenges.

NovImmune to present at BOS cmc 2012

Swiss bassed NovImmune to present a drug product case study at BOS cmc 2012.

Tillotts confirmed as Gold Sponsors for BOS cmc 2012

Bio2Business is pleased to announce that Swiss bassed Tillotts Services will be presenting at BOS cmc 2012 as Gold Sponsor. Joe Carey, Director of Business Development will be presenting. Tillotts are a leading contract service provider specialising in liquid-fill erncapsulation. See Tillotts homepage for further details.

KWS BioTest to exhibit at BOS 2012

KWS Biotest, leaders in preclinical contract research, to exhibit at BOS 2012, 25th September, London. Visit the KWS BioTest website (click here) to find out more information about KWS BioTest capabilities and expertise . Meet KWS representatives at booth 1, BOS 2012.

Bio2Business delighted to announce a new speaker for the small molecule track

Dr Christoph Rosenbohm, Director Chemistry and CMC, Santaris Pharma A/S will be delivering a drug substance focused presentation during the morning small molecule track

BASF confirm as Gold sponsors BOS cmc 2012

Bio2Business is pleased to announce that BASF, custom synthesis division, will be Gold Sponsors at BOS cmc 2012

Finland based Pharmatory Oy to return to BOS 2012 for 7th consecutive year

Finnish cGMP custom synthesis provider, Pharmatory Oy, return to BOS 2012 for the 7th consecutive year. Contact Johanna Heffernan prior to the event by visiting www.pharmatory.com

Dr Chris Langmead, Head of Pharmacology, Heptares to present at BOS 2012

Chris Langmead, Head of Pharmacology, Heptares confirms speakers participation at BOS 2012. Dr Langmead will discuss the challenges in outsourcing discovery pharmacology from the biotech perspective.

About Heptares: Heptares, a leading biotech based in the UK, is a pioneer in the discovery of new medicines targeting G-protein-coupled receptors (GPCRs). Visit www.heptares.com for further information.

Swiss based CARBOGEN AMCIS confirm Gold Sponsor package for the fourth consecutive year

Bio2Business are pleased to welcome back CARBOGEN AMCIS as Gold Sponsors for the fourth consecutive year

CARBOGEN AMCIS return to BOS 2012 for the fourth consecutive year

CARBOGEN AMCIS return to BOS 2012 as Gold Sponsors for the fourth consecutive year

Dr Mike Snowden, VP and Head of Discovery Sciences, AstraZeneca presents at BOS 2012

AstraZeneca, VP and Head of Discovery Sciences, Dr Mike Snowden to provide the opening presentation in the non-clinical track BOS 2012.

The provisional title for Dr Snowden's presentation is "Harnessing advances in translational research to approach attrition at discovery and how external R&D can effectively partner with Pharma".

Dr Christina Jespersgaard, Development Scientist Protein Separation and Virolgy, Novo Nordisk A/S to present large scale antibody case study for the biologics track

Bio2Business are delighted to extend a warm invitation to Dr Christina Jespersgaard, Development Scientist Protein Separation and Virology, Novo Nordisk A/S to the biologics track.  Christina will present a recent case study from 14.00-14.30 examining programme management of a large scale antibody production project which was outsourced to a CMO partner.